Home/Pipeline/Evolute® Punctal Plug Delivery System

Evolute® Punctal Plug Delivery System

Glaucoma / Ocular Hypertension

UnknownActive

Key Facts

Indication
Glaucoma / Ocular Hypertension
Phase
Unknown
Status
Active
Company

About Mati Therapeutics

Mati Therapeutics is pioneering a novel drug delivery approach in ophthalmology with its Evolute® Punctal Plug Delivery System, a small, cosmetically invisible device inserted into the tear duct. This platform aims to solve the critical problem of poor adherence to topical eye drop regimens, a major issue in managing chronic diseases like glaucoma. The company is led by founders with extensive experience from major ophthalmic players like Allergan and Abbott. Mati is positioned to address a significant unmet need in a large global market of patients with vision impairment from treatable causes.

View full company profile

Therapeutic Areas

Other Glaucoma / Ocular Hypertension Drugs

DrugCompanyPhase
BTQ 1902NovaliqPhase 2
iDose® TR (travoprost implant)GlaukosCommercial Launch
OTX-TICOcular TherapeutixPhase 1